1. What conditions has Ginseng been studied for?

• Metabolic disease: diabetes mellitus (including type 2 diabetes), obesity, fatty liver disease (mentioned in reviews of clinical studies and gut-microbiota-focused reviews).

• Cardiovascular disease: “cardiac and vascular diseases,” blood pressure, lipid profiles, platelet adhesion, and broader cardiovascular disorders (reviewed across animal and human studies).

• Neurologic and neurodegenerative disorders: cognition, memory, mood (clinical studies); Alzheimer’s disease (AD) and dementia (mechanistic and preclinical focus, especially ginsenoside Rg1).

• Cancer-related indications: anticancer effects broadly; cancer fatigue/well-being (clinical studies); glioma specifically using ginseng-derived exosome-like nanoparticles (GENs) in vitro and in vivo.

• Immune and infectious conditions: immunity support; common cold and flu (clinical studies); immune modulation in tumor microenvironment (T cells/Tregs, macrophage polarization) in glioma models.

• Gastrointestinal/inflammatory disease: inflammatory bowel disease (IBD)/colitis (GENs studied in cell models and DSS-induced colitis mice); diarrhea (mentioned in a gut-microbiota review).

• Sexual health and energy/stress: sexuality, energy, and “adaptogenic”/stress-related claims are described in reviews, with clinical literature summarized as mild-to-moderate effects overall.

• Cerebrovascular disease (comparative evidence): notoginseng is described as having superior protective effects on cerebrovascular disease, while ginseng is described as stronger for cardiovascular, nerve disease, cancer, and diabetes (comparative review).

• Sports performance: endurance performance enhancement (review of herbal ergogenics).

2. Does it work in treating those conditions? Summarize the evidence.

• Overall clinical effectiveness: A review of human clinical studies over ~20 years reports encouraging but generally mild-to-moderate benefits across several conditions (diabetes, cardiovascular disorders, cognition/mood, common cold/flu, cancer fatigue/well-being, quality of life). The same review emphasizes that future trials need better quality and better reporting of phytochemistry/quality control, implying current evidence is limited by heterogeneity and study design.

• Cardiovascular outcomes: A ginseng/ginsenoside cardiovascular review describes multiple plausible mechanisms (antioxidation, vasomotor control, ion channels/signal transduction, lipid profile improvement, blood pressure adjustment, improved cardiac function, reduced platelet adhesion) and states beneficial effects have been observed in animal models and humans. However, the study is a review and does not quantify clinical effect sizes; evidence strength cannot be fully judged from the study alone.

• Diabetes/metabolic disease: Clinical studies are reported for diabetes in the clinical-trials review, but effects are characterized as mild-to-moderate overall. A separate gut-microbiota-focused review argues ginseng may help prevent/treat metabolic diseases via microbiome regulation and that gut microbiota can transform ginsenosides; this is mechanistic/supportive rather than definitive clinical proof.

• Colitis/IBD (GENs): In DSS-induced colitis mice, ginseng-derived exosome-like nanoparticles (GENs) showed multiple benefits: suppression of TNF-α and IL-6 via NF-κB inhibition, longer colon length, reduced colon wall thickening, and longer survival (reported as 17 days vs 9 days in PBS controls). These are preclinical findings (mouse and cell models), not direct evidence that oral ginseng supplements treat human IBD.

• Glioma (GENs): GENs were reported to enhance targeting to the blood-brain barrier and glioma, recruit M1 macrophage expression in the tumor microenvironment, and inhibit tumor progression in vitro and in vivo. This is promising preclinical nanomedicine research, but it does not establish that standard ginseng supplements treat glioma in humans.

• Alzheimer’s disease (ginsenoside Rg1): A review focused on ginsenoside Rg1 reports in vitro and in vivo evidence for mechanisms relevant to AD (Aβ and Tau pathology, synaptic function, inflammation/oxidative stress/apoptosis, and gut microflora regulation; multiple signaling pathways). This is mechanistic and preclinical support; the study does not provide human RCT outcomes for AD.

• Common cold/flu and immune support: The clinical review lists common cold/flu among conditions with positive studies and notes a good safety record, but again characterizes effects as generally mild-to-moderate and calls for higher-quality trials.

• Sports/endurance performance: A sports-focused review states ginseng has been used as an endurance performance enhancer, but does not provide specific trial outcomes in the study; evidence strength and consistency cannot be determined from the study alone.

3. What health benefits does it have?

• Antioxidant and anti-inflammatory activity: Multiple reviews describe antioxidative and anti-inflammatory effects as core properties of ginseng/ginsenosides, with downstream relevance to cardiovascular, metabolic, neurologic, and inflammatory diseases.

• Cardiometabolic support (mechanistic and some human evidence): Reported benefits include improved vasomotor function, lipid profiles, blood pressure regulation, improved cardiac function, and reduced platelet adhesion (reviewed evidence across animal models and humans).

• Immune modulation: Ginseng is described as improving immunity; GENs studies suggest immune effects in disease contexts (e.g., macrophage polarization in glioma; cytokine suppression in colitis models).

• Cognition, memory, mood, and quality of life: Human clinical studies reviewed report benefits in cognition/memory/mood and quality of life/social functioning, though typically mild-to-moderate.

• Supportive care in cancer: Clinical literature reviewed includes cancer fatigue and well-being; preclinical GENs research suggests potential anti-tumor immune effects (especially in glioma models), but this is not the same as proven anticancer efficacy of supplements.

• Gut barrier/microbiome-related effects (preclinical and mechanistic): GENs showed intestinal retention and improved outcomes in colitis mice alongside microbiota shifts (e.g., decreased Firmicutes/Bacteroidota ratio). Separate reviews propose ginseng can regulate gut microbiota diversity and that microbiota can transform ginsenosides.

• Adaptogenic/stress-related claims: A clinical review describes ginseng as “adaptogenic,” stabilizing physiological processes and restoring homeostasis; however, the study-level evidence summary suggests effects in humans are generally mild-to-moderate and trial quality varies.

4. Does it have any downsides or side effects?

• Drug interaction potential: One review notes ginseng “may have drug interactions,” though it is described as relatively safe overall. Another abstract on supplement–drug interactions categorizes Asian ginseng among supplements that “may cause interactions with a few medications but are likely to be safe with other medications,” and American ginseng among those with a “low likelihood of drug interactions” with caveats. These are general statements; specific interacting drugs are not listed in the studies reviewed here.

• Safety record in humans: The clinical review reports a “good safety record” in humans across trials, implying adverse effects were not prominent in the summarized literature, but it does not provide rates or specific adverse events in the study.

• Product quality/contamination risks (general supplement concern): A sports-supplement review warns that some herbal products may contain banned ingredients or inappropriate amounts/fake supplements, and that there is no guarantee herbal supplements are safe for anyone. This is not specific to ginseng alone, but it is a practical downside relevant to real-world use.

• Formulation-specific uncertainty: Some of the most striking effects in the studies involve GENs (ginseng-derived exosome-like nanoparticles), which are not standard over-the-counter ginseng products; safety and side effects may differ by formulation and dose, and human safety for GENs is not established in these studies.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report specific pharmacogenomic findings (e.g., genotype-stratified responses, variants in drug-metabolizing enzymes/transporters, or HLA-associated adverse reactions) for ginseng or ginsenosides.

• What is indirectly relevant: Several studies emphasize that ginseng’s effects depend on complex mixtures (ginsenosides, polysaccharides, etc.) and that gut microbiota can transform ginsenosides. While not genetics per se, this suggests inter-individual variability in exposure and response, but no specific human genetic variants are identified.

• Bottom line: Based on these studies alone, there is insufficient evidence to say ginseng is beneficial or harmful for particular genetic subgroups.

Panax Ginseng Overview

Panax ginseng C.A. Meyer has been esteemed in Asia for millennia and is gaining global recognition for its potential health benefits. Utilized as a nutrient, beverage, cosmetic, dye, and medicine, comprehensive papers have addressed its chemopreventive effects and cultural significance.

Research on Cognitive and Mood Effects

A study with healthy young adults using a placebo-controlled, double-blind, randomized, crossover trial showed that ginseng can improve mood and working memory. A 200 mg dose maintained mood levels and slowed response times in mental tasks, while a 400 mg dose enhanced calmness and performance. However, the benefits did not increase with repeated ingestion over eight days.

Chronic Effects on Mood and Affect

In a double-blind, placebo-controlled trial, ginseng supplementation at 200 mg or 400 mg for eight weeks did not significantly affect mood or affect in healthy young adults, contradicting common claims of ginseng's psychological benefits.

Impact on Health-Related Quality of Life

Over eight weeks, 200 mg/day of Panax ginseng improved aspects of mental health and social functioning at the four-week mark, but these improvements were not sustained at eight weeks. Adverse effects were slightly higher in the ginseng group, but not statistically significant.

Cognitive Function Research

Evidence on ginseng's effects on cognition is mixed, with certain ginsenosides showing promise in neuroprotection and neurotransmission. Nonetheless, well-conducted trials are necessary to establish any definitive cognitive benefits.

Ginseng and Ginkgo Biloba on Cognitive Performance

Studies of Panax ginseng and Ginkgo biloba indicate improvements in secondary memory and cognitive tasks in healthy young adults. While ginseng enhanced memory task speed and attention accuracy, ginkgo improved arithmetic task performance.

Ginseng's Mechanisms of Action

Research suggests that Panax ginseng may enhance cognitive performance and reduce mental fatigue, potentially through immediate effects on blood glucose regulation.

Immunomodulatory Effects

Ginseng extract and specific ginsenosides have been shown to improve immune responses in cattle and guinea pigs when used as vaccine adjuvants. In pigs, ginseng enhanced antibody responses against porcine parvovirus and Erysipelothrix rhusiopathiae.

Enhancing Influenza Vaccine Response

A standardized ginseng extract, G115, effectively enhanced immune responses to influenza vaccination and reduced the incidence of the common cold in a study involving volunteers, with no significant safety concerns reported.

Systematic Review on Ginseng's Effectiveness

A systematic review found strong evidence for ginseng's positive effects on glucose metabolism, psychomotor functions, and pulmonary disease. However, it does not appear to enhance physical performance and is generally safe with low adverse effects.

Anti-inflammatory Properties of Ginsenosides

Ginsenosides, the active components of Panax ginseng, exhibit anti-inflammatory properties by affecting cytokine production and signaling pathways, offering potential for treating inflammatory conditions.

References:

1. Brief introduction of Panax ginseng C.A. Meyer
2. Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults
3. Ginseng does not enhance psychological well-being in healthy, young adults: results of a double-blind, placebo-controlled, randomized clinical trial
4. Effects of Panax ginseng on quality of life
5. Effects and mechanisms of ginseng and ginsenosides on cognition
6. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults
7. Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity
8. Adjuvant effect of ginseng extracts on the immune responses to immunisation against Staphylococcus aureus in dairy cattle
9. Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants
10. Ginseng extract in aluminium hydroxide adjuvanted vaccines improves the antibody response of pigs to porcine parvovirus and Erysipelothrix rhusiopathiae
11. Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]
12. Systematic review of randomized controlled trials evaluating the efficacy and safety of ginseng
13. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases
14. Pharmacological potential of ginseng and its major component ginsenosides.
    Zubair Ahmed Ratan, Mohammad Faisal Haidere, Yo Han Hong, Sang Hee Park, Jeong-Oog Lee, Jongsung Lee, Jae Youl Cho (2021) - Journal of ginseng research
15. Anti-glioma effect of ginseng-derived exosomes-like nanoparticles by active blood-brain-barrier penetration and tumor microenvironment modulation.
    Jisu Kim, Ying Zhu, Sunhui Chen, Dongdong Wang, Shuya Zhang, Jiaxuan Xia, Shiyi Li, Qiujun Qiu, Hyukjin Lee, Jianxin Wang (2023) - Journal of nanobiotechnology
16. Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy.
    Hanbing Liu, Xiaoyan Lu, Yang Hu, Xiaohui Fan (2020) - Pharmacological research
17. Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines.
    Jisu Kim, Shuya Zhang, Ying Zhu, Ruirui Wang, Jianxin Wang (2023) - Journal of ginseng research
18. Pharmacological Effects of Ginseng: Multiple Constituents and Multiple Actions on Humans.
    Guolin Zhou, Chong-Zhi Wang, Somayeh Mohammadi, Wamtinga R Sawadogo, Qinge Ma, Chun-Su Yuan (2023) - The American journal of Chinese medicine
19. New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease.
    Jiao-Jiao Wu, Yu Yang, Yan Wan, Jia Xia, Jin-Feng Xu, Li Zhang, Dong Liu, Lu Chen, Fei Tang, Hui Ao, Cheng Peng (2022) - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
20. Chemical Structures and Pharmacological Profiles of Ginseng Saponins.
    Ze-Yu Shi, Jin-Zhang Zeng, Alice Sze Tsai Wong (2019) - Molecules (Basel, Switzerland)
21. Panax Ginseng in the treatment of Alzheimer's disease and vascular dementia.
    Zhiyong Wang, Zhen Zhang, Jiangang Liu, Mingdong Guo, Hao Li (2023) - Journal of ginseng research
22. Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation.
    Zhaoqiang Chen, Zepeng Zhang, Jiaqi Liu, Hongyu Qi, Jing Li, Jinjin Chen, Qingxia Huang, Qing Liu, Jia Mi, Xiangyan Li (2022) - Frontiers in cellular and infection microbiology
23. Immunomodulatory, Anti-Inflammatory, and Anti-Cancer Properties of Ginseng: A Pharmacological Update.
    Jose Antonio Valdés-González, Marta Sánchez, Ignacio Moratilla-Rivera, Irene Iglesias, María Pilar Gómez-Serranillos (2023) - Molecules (Basel, Switzerland)
24. Common Herbal Dietary Supplement-Drug Interactions.
    Gary N Asher, Amanda H Corbett, Roy L Hawke (2017) - American family physician
25. Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives.
    Xing Huang, Ning Li, Yiqiong Pu, Tong Zhang, Bing Wang (2019) - Molecules (Basel, Switzerland)
26. Herbal medicine for sports: a review
    Maha Sellami, Olfa Slimeni, Andrzej Pokrywka, Goran Kuvačić, Lawrence D Hayes (2018)
27. Targeting pyroptosis: A novel strategy of ginseng for the treatment of diabetes and its chronic complications.
    Ke Li, Ya-Jun Wang, Chen Chen, Xiao-Jie Wang, Wei Li (2025) - Phytomedicine : international journal of phytotherapy and phytopharmacology
28. Red ginseng monograph.
    Seung-Ho So, Jong Won Lee, Young-Sook Kim, Sun Hee Hyun, Chang-Kyun Han (2018) - Journal of ginseng research
29. A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng.
    Yage Liu, Hao Zhang, Xuan Dai, Ruyuan Zhu, Beibei Chen, Bingke Xia, Zimengwei Ye, Dandan Zhao, Sihua Gao, Alexander N Orekhov, Dongwei Zhang, Lili Wang, Shuzhen Guo (2021) - Phytomedicine : international journal of phytotherapy and phytopharmacology
30. A Review of Authenticity and Authentication of Commercial Ginseng Herbal Medicines and Food Supplements.
    Mihael Cristin Ichim, Hugo J de Boer (2020) - Frontiers in pharmacology
31. Ginseng as a therapeutic target to alleviate gut and brain diseases via microbiome regulation.
    Hamid Iqbal, Yihyo Kim, Mirim Jin, Dong-Kwon Rhee (2025) - Journal of ginseng research

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!